MLS® and COVID-19: a new success in treating interstitial pneumonia

02 October 2020 - Research -
Share

A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.

An obese patient with interstitial pneumonia who was treated for 4 days with MLS® Laser Therapy reported a concrete and progressive improvement in her critical parameters such as oxygen saturation, which increased to 97-99%, radiographic assessment of the pulmonary oedema (RALE) which went from 8 to 2, Brescia-COVID Respiratory Severity Scale (a score which assesses the gravity of the pneumonia and is used for patient progress management) which went from 4 to 0 and SMART-COP (a tool which monitors the seriousness of the pneumonia and predicts the need for intervening such as with a move to intensive care, etc.) which dropped from 5 to 1. Interleukin-6, ferritin and C-reactive protein also recorded a significant contraction.

The data were reported by the study “Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report” whose conclusions indicate that use of MLS® Laser Therapy for the case in question recorded a significant improvement of the respiratory indexes, radiological results and inflammatory markers in just a few days.

A result which suggests that ASA’s therapy can safely be combined with conventional treatment for patients suffering from severe COVID-19 and morbid obesity.

Max 980px
Blog - obese patient with severe COVID-19 pneumonia assessment
Blog - COVID19 case report - laser beam positioning
COVID19 case report - Radiographic assessment of lung edema - Before MLS
COVID19 case report - Radiographic assessment of lung edema - After MLS

You might also be interested in ...

See all articles

press - 01/09/2020
NBC Boston News: MLS® treats a Covid-19 patient effectively
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
MLS Laser Therapy for the treatment of COVID19 pneumonia
blog - 24/08/2020
Covid–19 pneumonia and MLS®: a successful case history
A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19 reported a significant improvement in some basic parameters...
MLS Laser Therapy in a morbidly obese patient with severe COVID-19 pneumonia
Research
Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report
S.A. Sigman, S. Mokmeli, M.A. Vetrici Canadian Journal of Respiratory Therapy, 56:52–56, 2020
Blog - 11/09/2024
The efficacy of MLS® Laser Therapy in the treatment of Radiation-Induced Oral Mucositis
This research, conducted using the M6 robotic device, is the first of its kind to explore this application, offering new hope to patients suffering from this debilitating side effect of radiotherapy.
Press - 09/09/2024
Italia Informa: ASA focuses on Welfare
Benefits, training and initiatives aimed at improving not just the working day are the basis of ASA’s 2024 welfare plan which considers its collaborators’ well-being a trump card.
Press - 05/09/2024
Notas de Actualidad: M8 against pain for the best quality of life
The Colombian newspaper in Barranquilla “Notas de actualidad” has no doubts: the “made in Italy” M8 laser device allows reducing pain and restoring the best quality of life to patients suffering from...